Geriatric Hip Fracture
Conditions
Keywords
Geriatrics, Hip Fractures, APACHE II, Mortality, Morbidity
Brief summary
This study aims to compare the Nottingham Hip Fracture Score (NHFS) and the Acute Physiology and Chronic Health Evaluation II (APACHE II) score in predicting 30-day mortality in geriatric patients over 60 years old undergoing hip fracture surgery.
Detailed description
The study aim to compare the Nottingham Hip Fracture Score (NHFS) and the Acute Physiology and Chronic Health Evaluation II (APACHE II) score in predicting 30-day mortality in geriatric patients over 60 years undergoing hip fracture surgery. This study was conducted at the Tata Main Hospital in Jamshedpur, India. The study was designed as a prospective observational study, with data collected from June 2022 to June 2023. The study's primary objective was to predict mortality in patients undergoing hip fracture surgery. The study also investigated secondary outcomes such as the need for postoperative ventilator and ionotropic support, the occurrence of acute kidney injury, cardiac morbidity, and the presence of pulmonary embolism and deep vein thrombosis, as well as length of stay.
Interventions
OTHERNottingham Hip Fracture Score (NHFS) score
Nottingham Hip Fracture Score (NHFS) score in patients above 60 years undergoing hip fracture surgery.
OTHERAcute Physiology and Chronic Health Evaluation (APACHE)-II score
Acute Physiology and Chronic Health Evaluation (APACHE)-II score in patients above 60 years undergoing hip fracture surgery
Sponsors
Tata Main Hospital
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Age more than or equal to 60 years, Underwent Hip fracture surgeries, of Either Sex \-
Exclusion criteria
Age less than 60 years of age, Hip fractures not undergoing any invasive surgery, Implant removals planned for healed hip fractures, Re-explorations during the same admission in which primary surgery was conducted \-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mortality | 30 days | Mortality at least 30 days after surgery or death (during hospital stay or within 30 days after surgery. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Length of Stay (LOS) | 30 days | Length of Stay (LOS) in the hospital |
Countries
India
Outcome results
None listed